Titan Biotech Limited Press Release Sep 30 2026
Filed with BSE · · 2 pages · English
Summary by 6ix AI
Titan Biotech Limited has filed a disclosure regarding an alteration to its Memorandum of Association, specifically the capital clause, due to an increase in authorized share capital. The authorized share capital will rise from a specified amount divided into a certain number of equity shares to a new amount divided into a larger number of equity shares. Details of the amendment are provided in an annexure accompanying the filing.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Titan Biotech
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Titan Biotech Limited Press Release Sep 29 2026
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Titan Biotech Limited Press Release Sep 10 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Later from Titan Biotech
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Announcement under Regulation 30 (LODR)-Allotment
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech